vs
Amarin Corp plc（AMRN）与MID PENN BANCORP INC（MPB）财务数据对比。点击上方公司名可切换其他公司
MID PENN BANCORP INC的季度营收约是Amarin Corp plc的1.4倍（$62.0M vs $45.1M），MID PENN BANCORP INC净利率更高（31.4% vs -23.3%，领先54.6%），MID PENN BANCORP INC同比增速更快（30.8% vs 7.0%），过去两年MID PENN BANCORP INC的营收复合增速更高（21.1% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
该资料实际介绍的是1973年成立于新泽西州切里希尔的商业银行，该银行在2007年被多伦多道明银行收购，并入其旗下的TD Banknorth，之后TD Banknorth统一更名为TD银行。
AMRN vs MPB — 直观对比
营收规模更大
MPB
是对方的1.4倍
$45.1M
营收增速更快
MPB
高出23.8%
7.0%
净利率更高
MPB
高出54.6%
-23.3%
两年增速更快
MPB
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $62.0M |
| 净利润 | $-10.5M | $19.4M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 43.6% |
| 净利率 | -23.3% | 31.4% |
| 营收同比 | 7.0% | 30.8% |
| 净利润同比 | 33.0% | 47.0% |
| 每股收益（稀释后） | — | $0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNMPB
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $62.0M | ||
| Q3 25 | $49.7M | $61.8M | ||
| Q2 25 | $72.7M | $54.3M | ||
| Q1 25 | $42.0M | $47.7M | ||
| Q4 24 | $62.3M | $47.4M | ||
| Q3 24 | $42.3M | $45.3M | ||
| Q2 24 | $67.5M | $44.1M |
净利润AMRNMPB
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $19.4M | ||
| Q3 25 | $-7.7M | $18.3M | ||
| Q2 25 | $-14.1M | $4.8M | ||
| Q1 25 | $-15.7M | $13.7M | ||
| Q4 24 | $-48.6M | $13.2M | ||
| Q3 24 | $-25.1M | $12.3M | ||
| Q2 24 | $1.5M | $11.8M |
毛利率AMRNMPB
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNMPB
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 43.6% | ||
| Q3 25 | -22.4% | 39.3% | ||
| Q2 25 | -22.0% | 7.9% | ||
| Q1 25 | -39.9% | 35.2% | ||
| Q4 24 | -84.3% | 34.1% | ||
| Q3 24 | -59.5% | 32.8% | ||
| Q2 24 | -0.8% | 32.4% |
净利率AMRNMPB
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 31.4% | ||
| Q3 25 | -15.6% | 29.6% | ||
| Q2 25 | -19.4% | 8.8% | ||
| Q1 25 | -37.4% | 28.8% | ||
| Q4 24 | -78.0% | 27.9% | ||
| Q3 24 | -59.4% | 27.1% | ||
| Q2 24 | 2.3% | 26.7% |
每股收益（稀释后）AMRNMPB
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.83 | ||
| Q3 25 | $-0.02 | $0.79 | ||
| Q2 25 | $-0.03 | $0.22 | ||
| Q1 25 | $-0.04 | $0.71 | ||
| Q4 24 | $-0.12 | $0.72 | ||
| Q3 24 | $-0.06 | $0.74 | ||
| Q2 24 | $0.00 | $0.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $814.1M |
| 总资产 | $645.8M | $6.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNMPB
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | — | ||
| Q3 25 | $286.6M | — | ||
| Q2 25 | $298.7M | — | ||
| Q1 25 | $281.8M | — | ||
| Q4 24 | $294.2M | — | ||
| Q3 24 | $305.7M | — | ||
| Q2 24 | $306.7M | — |
股东权益AMRNMPB
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $814.1M | ||
| Q3 25 | $458.9M | $796.3M | ||
| Q2 25 | $464.9M | $775.7M | ||
| Q1 25 | $473.7M | $667.9M | ||
| Q4 24 | $486.2M | $655.0M | ||
| Q3 24 | $531.4M | $573.1M | ||
| Q2 24 | $551.9M | $559.7M |
总资产AMRNMPB
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $6.1B | ||
| Q3 25 | $659.8M | $6.3B | ||
| Q2 25 | $670.1M | $6.4B | ||
| Q1 25 | $655.7M | $5.5B | ||
| Q4 24 | $685.3M | $5.5B | ||
| Q3 24 | $750.6M | $5.5B | ||
| Q2 24 | $799.9M | $5.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $80.0M |
| 自由现金流经营现金流 - 资本支出 | — | $71.8M |
| 自由现金流率自由现金流/营收 | — | 115.8% |
| 资本支出强度资本支出/营收 | — | 13.3% |
| 现金转化率经营现金流/净利润 | — | 4.12× |
| 过去12个月自由现金流最近4个季度 | — | $132.1M |
8季度趋势，按日历期对齐
经营现金流AMRNMPB
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $80.0M | ||
| Q3 25 | $-12.7M | $26.3M | ||
| Q2 25 | $16.6M | $29.0M | ||
| Q1 25 | $-12.5M | $11.5M | ||
| Q4 24 | $-13.3M | $51.4M | ||
| Q3 24 | $-2.4M | $16.9M | ||
| Q2 24 | $-2.7M | $18.0M |
自由现金流AMRNMPB
| Q1 26 | — | — | ||
| Q4 25 | — | $71.8M | ||
| Q3 25 | — | $24.3M | ||
| Q2 25 | — | $27.2M | ||
| Q1 25 | — | $8.8M | ||
| Q4 24 | — | $44.5M | ||
| Q3 24 | — | $16.8M | ||
| Q2 24 | — | $17.7M |
自由现金流率AMRNMPB
| Q1 26 | — | — | ||
| Q4 25 | — | 115.8% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 50.1% | ||
| Q1 25 | — | 18.4% | ||
| Q4 24 | — | 93.8% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 40.2% |
资本支出强度AMRNMPB
| Q1 26 | — | — | ||
| Q4 25 | — | 13.3% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 5.7% | ||
| Q4 24 | — | 14.6% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.7% |
现金转化率AMRNMPB
| Q1 26 | — | — | ||
| Q4 25 | — | 4.12× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 6.08× | ||
| Q1 25 | — | 0.84× | ||
| Q4 24 | — | 3.88× | ||
| Q3 24 | — | 1.37× | ||
| Q2 24 | -1.81× | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
MPB
暂无分部数据
